(2,2-dimethyladamant-1-yl)amine | 1404434-73-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (2,2-dimethyladamant-1-yl)amine
• 英文别名: Dimethyladamantanamine；2,2-dimethyladamantan-1-amine
• CAS: 1404434-73-6
• 化学式: C₁₂H₂₁N
• 分子量: 179.305
• InChiKey: KQVMJTUONQGSFE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (2,2-dimethyladamant-1-yl)amine 在 盐酸 、 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 甲醇 、 乙醚 、 水 、 乙腈 为溶剂， 反应 42.04h， 生成 N-benzyl-N-methyl(2,2-dimethyladamant-1-yl)amine
  参考文献：
  名称：

  Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds

  摘要：

  The synthesis of several 2,2-dialkyladamantyl-1-amines through the combination of a Ritter reaction with a Wagner-Meerwein rearrangement from noradamantane alcohols is reported. Several of the novel amines displayed low micromolar activities against several H1N1 influenza virus strains, including the amantadine-resistant A/PuertoRico/8/34 strain. Most of the compounds did not show cytotoxicity for MDCK cells.

  DOI：

  10.1021/ml300279b
• 作为产物：
  描述：

  N-(2,2-dimethyladamant-1-yl)-2-chloroacetamide 在 溶剂黄146 、 硫脲 作用下， 以 乙醇 为溶剂， 以2.65 g的产率得到(2,2-dimethyladamant-1-yl)amine
  参考文献：
  名称：

  Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds

  摘要：

  The synthesis of several 2,2-dialkyladamantyl-1-amines through the combination of a Ritter reaction with a Wagner-Meerwein rearrangement from noradamantane alcohols is reported. Several of the novel amines displayed low micromolar activities against several H1N1 influenza virus strains, including the amantadine-resistant A/PuertoRico/8/34 strain. Most of the compounds did not show cytotoxicity for MDCK cells.

  DOI：

  10.1021/ml300279b

文献信息

• [EN] BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT<br/>[FR] DÉRIVÉS DE BENZODIAZÉPINE, COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE LA DÉFICIENCE COGNITIVE
  申请人：MEKONNEN BELEW

  公开号：WO2016205739A1

  公开（公告）日：2016-12-22

  This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those benzodiazepine derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with central nervous system (CNS) disorders. In particular, it relates to the use of a α5- containing GABAA receptor agonist (e.g., a α5-containing GABAA receptor positive allosteric modulator) as described herein in treating cognitive impairment associated with central nervous system (CNS) disorders in a subject in need or at risk thereof, including, without limitation, subjects having or at risk for age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI (aMCI), Age- Associated Memory Impairment (AAMI), Age Related Cognitive Decline (ARCD), dementia, Alzheimer' s Disease(AD), prodromal AD, post traumatic stress disorder (PTSD), schizophrenia, bipolar disorder, amyotrophic lateral sclerosis (ALS), cancer-therapy-related cognitive impairment, mental retardation, Parkinson' s disease (PD), autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction.

  这项发明涉及苯二氮卓啉衍生物，包括含有这些苯二氮卓啉衍生物的治疗有效量的组合物，以及使用这些衍生物或组合物治疗与中枢神经系统（CNS）疾病相关的认知障碍的方法。具体而言，它涉及在需要或有风险的受试者中治疗与中枢神经系统（CNS）疾病相关的认知障碍，包括但不限于具有或有风险患上与年龄相关的认知障碍、轻度认知障碍（MCI）、遗忘性MCI（aMCI）、年龄相关记忆障碍（AAMI）、年龄相关认知衰退（ARCD）、痴呆症、阿尔茨海默病（AD）、前驱期AD、创伤后应激障碍（PTSD）、精神分裂症、躁郁症、肌萎缩侧索硬化（ALS）、癌症治疗相关认知障碍、智力障碍、帕金森病（PD）、自闭症谱系障碍、脆性X综合症、雷特综合症、强迫行为和物质成瘾。
• Phosphorus compound
  申请人：——

  公开号：US20030109736A1

  公开（公告）日：2003-06-12

  The phosphorus-containing compound of the present invention is represented by the following formula (I), (II) or (III): 1 wherein Z 1 , Z 2 and Z 3 each represents a cycloalkane, a cycloalkene, a polycyclic aliphatic hydrocarbon or an aromatic hydrocarbon rings which may have a substituent; R represents a halogen atom, a hydroxyl, a carboxyl, a halocarboxyl (haloformyl), an alkyl, an alkoxy, an alkenyl or an aryl groups; A represents a polyvalent group corresponding to an alkane; Y 1 , Y 2 and Y 3 each represents —O—, —S— or —NR 1 —, wherein R 1 represents a hydrogen atom or an alkyl group; k is an integer of to 6; m is an integer of 0 to 2; n is an integer of not less than 1; q is an integer of 0 to 5; r is 0 or 1; and S is an integer of 1 to 4. The phosphorus-containing compound is excellent in heat resistance and is useful as flame retardants, plasticizers, or stabilizers.

  本发明的含磷化合物由以下式(I)、(II)或(III)表示：其中Z1、Z2和Z3分别表示可能具有取代基团的环烷烃、环烯烃、多环脂肪烃或芳香烃环；R表示卤素原子、羟基、羧基、卤代羧基（卤甲酰基）、烷基、烷氧基、烯基或芳基；A表示对应于烷烃的多价基团；Y1、Y2和Y3分别表示—O—、—S—或—NR1—，其中R1表示氢原子或烷基；k为0至6的整数；m为0至2的整数；n为不少于1的整数；q为0至5的整数；r为0或1；S为1至4的整数。这种含磷化合物具有优异的耐热性，可用作阻燃剂、增塑剂或稳定剂。
• METHODS OF USE OF ANTIVIRAL COMPOUNDS
  申请人：Wang Jizhou

  公开号：US20110065766A1

  公开（公告）日：2011-03-17

  The present invention relates, in part, to methods of treatment, prevention, and inhibition of viral disorders. In one aspect, the present invention relates to inhibition of the M2 proton channel of influenza viruses (e.g. influenza A virus) and other similar viroporins (e.g., VP24 of Ebola and Marburg viruses; and NS3 protein of Bluetongue). The present invention further relates, inter alia, to compounds which have been shown to possess antiviral activity, in particular, inhibiting the M2 proton channel of influenza viruses.

  本发明涉及部分治疗、预防和抑制病毒性疾病的方法。在一个方面，本发明涉及抑制流感病毒（例如流感A病毒）和其他类似的病毒孔蛋白（例如埃博拉和马尔堡病毒的VP24；以及蓝舌病的NS3蛋白）的M2质子通道。本发明还涉及已被证明具有抗病毒活性的化合物，特别是抑制流感病毒M2质子通道的化合物。
• Adamantylamine/long chain alkylamine catalysts and use in paraffin-olefin alkylation process
  申请人：EXXON RESEARCH AND ENGINEERING COMPANY

  公开号：EP0139504A1

  公开（公告）日：1985-05-02

  A process and new surfactant/hydride transfer catalyst compositions are described for paraffin-olefin alkylation under strong acid conditions in which a mixture of one or more adamantane derivatives and one or more surfactants are used to substantially improve the efficiency of reaction while significantly minimizing cracking side reactions.

  描述了一种在强酸条件下进行石蜡-烯烃烷基化的工艺和新型表面活性剂/氢转移催化剂组合物，其中使用了一种或多种金刚烷衍生物和一种或多种表面活性剂的混合物，以大幅提高反应效率，同时显著减少裂解副反应。
• PHOSPHORUS COMPOUND
  申请人：Daicel Chemical Industries, Ltd.

  公开号：EP1277758A1

  公开（公告）日：2003-01-22

  The phosphorus-containing compound of the present invention is represented by the following formula (I), (II) or (III):    wherein Z1, Z2 and Z3 each represents a cycloalkane, a cycloalkene, a polycyclic aliphatic hydrocarbon or an aromatic hydrocarbon rings which may have a substituent; R represents a halogen atom, a hydroxyl, a carboxyl, a halocarboxyl (haloformyl), an alkyl, an alkoxy, an alkenyl or an aryl groups; A represents a polyvalent group corresponding to an alkane; Y1, Y2 and Y3 each represents -O-, -S- or -NR1-, wherein R1 represents a hydrogen atom or an alkyl group; k is an integer of 1 to 6; m is an integer of 0 to 2; n is an integer of not less than 1; q is an integer of 0 to 5; r is 0 or 1; and s is an integer of 1 to 4. The phosphorus-containing compound is excellent in heat resistance and is useful as flame retardants, plasticizers, or stabilizers.

  本发明的含磷化合物由下式（I）、（II）或（III）表示： 其中，Z1、Z2 和 Z3 分别代表环烷、环烯、多环脂肪烃或芳香烃环，这些环可能具有取代基；R 代表卤素原子、羟基、羧基、卤代烃基（卤代甲酰基）、烷基、烷氧基、烯基或芳基；A代表对应于烷烃的多价基团；Y1、Y2 和 Y3 各自代表-O-、-S- 或-NR1-，其中 R1 代表氢原子或烷基；k 是 1 至 6 的整数；m 是 0 至 2 的整数；n 是不小于 1 的整数；q 是 0 至 5 的整数；r 是 0 或 1；以及 s 是 1 至 4 的整数。 含磷化合物具有优异的耐热性，可用作阻燃剂、增塑剂或稳定剂。